In a company release, Accuray Inc. announced its CyberKnife radiotherapy platform, which delivers stereotactic radiosurgery to treat lesions in the brain, was supported by more than 2 decades of ...
SUNNYVALE, Calif., March 31, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that long-term follow-up data from a study of men and women with trigeminal neuralgia (TN) showed ...
July is National Bone Cancer Awareness Month. Shannon D. Cox, M.D., board-certified radiation oncologist at Austin CyberKnife, spoke with Studio 512 Co-Host Rosie Newberry about bone cancer — ...
Dublin, Oct. 27, 2025 (GLOBE NEWSWIRE) -- The "Cyberknife Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering. The CyberKnife market is redefining precision ...
The CyberKnife® Robotic Radiosurgery System at Saint Peter‘s University Hospital is a pain-free, noninvasive alternative to surgery that can effectively treat complex tumors located virtually anywhere ...
SUNNYVALE, Calif., Sept. 17, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announces that The Lancet Oncology, a high impact and leading global peer-reviewed oncology journal, has published ...
February 8, 2012 — Cyberknife radiosurgery to relieve trigeminal neuralgia refractory to medical management is a promising, viable alternative to more invasive treatment for this painful condition, ...
MADISON, Wis., April 3, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that new data on the clinical use of the CyberKnife® System reinforce the device's broad-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback